EPS Bio Technology Corp.

Total Valuation

EPS Bio Technology Corp. carries a market capitalization of 347.48M, placing it among publicly traded companies globally. Its enterprise value stands at 456.26M, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.

Share Statistics

EPS Bio Technology Corp. currently has 23.80M shares outstanding.

Valuation Ratios

EPS Bio Technology Corp. trades at a trailing price-to-earnings ratio of 98.85. The price-to-sales ratio is 1.01, and the price-to-book ratio stands at 2.09.

Enterprise Valuation

On an enterprise value basis, EPS Bio Technology Corp. trades at an EV/EBITDA multiple of 15.26 and an EV/FCF ratio of 218.37. The EV/Sales ratio of 0.97 reflects the premium investors are willing to pay for the company's revenue stream, while the EV/EBIT multiple of 15.26 provides insight into valuation relative to core operating earnings.

Financial Position

EPS Bio Technology Corp. maintains a current ratio of 2.19, meaning it holds 2.2x the short-term assets needed to cover near-term liabilities. The debt-to-equity ratio is 37.42, indicating elevated leverage, while an interest coverage ratio of -3.04 demonstrates limited ability to service its debt obligations.

Financial Efficiency

EPS Bio Technology Corp. posts a return on equity of -5.88 and a return on invested capital of 6.74.

Taxes

Over the trailing twelve months, EPS Bio Technology Corp. has paid -5.51M in income taxes, reflecting an effective tax rate of 20.41.

Stock Price Statistics

EPS Bio Technology Corp.'s stock has declined approximately -29.29782% over the past 52 weeks. The 50-day moving average sits at 13.67, while the 200-day moving average is 16.11.

Income Statement

Over the trailing twelve months, EPS Bio Technology Corp. generated 469.46M in revenue and converted that into -14.24M in net income, yielding earnings per share of -0.60. EBITDA reached -5.99M, while operating income came in at -5.99M.

Balance Sheet

EPS Bio Technology Corp. holds 120.22M in cash and equivalents against 103.58M in total debt, resulting in a net debt position of -108.52M. Total book value stands at 226.23M, with working capital of 198.32M providing operational flexibility.

Cash Flow

EPS Bio Technology Corp. produced -13.41M in operating cash flow over the past twelve months. After subtracting -14.08M in capital expenditures, free cash flow totaled -27.49M - equivalent to -1.15 per share.

Margins

EPS Bio Technology Corp. operates with a gross margin of 18.51, reflecting its pricing power and cost economics. The operating margin of -1.28 and net profit margin of -3.03 provide insight into operational efficiency.

Dividends & Yields

Stock Splits

EPS Bio Technology Corp.'s most recent stock split took place on October 8, 2014 with a 25:26 split ratio.

Scores

EPS Bio Technology Corp. posts an Altman Z-Score of 2.30, near the 3.0 threshold that indicates strong financial health and minimal bankruptcy risk.